Medivie Therapeutic Ltd (MDVI) - Cash Flow Conversion Efficiency

Latest as of June 2021: 0.217x

Based on the latest financial reports, Medivie Therapeutic Ltd (MDVI) has a cash flow conversion efficiency ratio of 0.217x as of June 2021. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-966.00K ≈ $-2.59K USD) by net assets (ILA-4.46 Million ≈ $-11.95K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see MDVI company net worth for the company's overall valuation and market capitalisation.

Medivie Therapeutic Ltd - Cash Flow Conversion Efficiency Trend (2010–2020)

This chart illustrates how Medivie Therapeutic Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Medivie Therapeutic Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Medivie Therapeutic Ltd ranked by their cash flow conversion efficiency. Explore earnings quality score of Medivie Therapeutic Ltd to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Sosandar Plc LSE:SOS	0.053x
Palace Capital PLC LSE:PCA	0.028x
Metgasco Ltd AU:MEL	0.075x
PT Sreeya Sewu Indonesia Tbk JK:SIPD	-0.047x
Nevada Zinc Corp V:NZN	0.109x
Zanaga Iron Ore Co Ltd LSE:ZIOC	0.000x
Sparx Technology Inc V:SPRX	0.114x
Israel Opportunity - Energy Resources LP TA:ISOP-L	-0.055x

Annual Cash Flow Conversion Efficiency for Medivie Therapeutic Ltd (2010–2020)

The table below shows the annual cash flow conversion efficiency of Medivie Therapeutic Ltd from 2010 to 2020. View today's stock price for Medivie Therapeutic Ltd for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2020-12-31	ILA3.73 Million ≈ $10.00K	ILA-3.88 Million ≈ $-10.41K	-1.041x	-81.64%
2019-12-31	ILA5.88 Million ≈ $15.76K	ILA-3.37 Million ≈ $-9.03K	-0.573x	-38.84%
2018-12-31	ILA12.18 Million ≈ $32.65K	ILA-5.03 Million ≈ $-13.48K	-0.413x	-127.05%
2017-12-31	ILA16.26 Million ≈ $43.60K	ILA-2.96 Million ≈ $-7.93K	-0.182x	+97.06%
2016-12-31	ILA577.00K ≈ $1.55K	ILA-3.57 Million ≈ $-9.58K	-6.194x	-192.21%
2015-12-31	ILA-527.00K ≈ $-1.41K	ILA-3.54 Million ≈ $-9.49K	6.717x	+605.14%
2014-12-31	ILA2.26 Million ≈ $6.05K	ILA-3.00 Million ≈ $-8.04K	-1.330x	-172.72%
2013-12-31	ILA-1.52 Million ≈ $-4.08K	ILA-2.79 Million ≈ $-7.47K	1.829x	+117.83%
2012-12-31	ILA1.22 Million ≈ $3.27K	ILA-12.52 Million ≈ $-33.57K	-10.254x	-172.59%
2011-12-31	ILA3.65 Million ≈ $9.80K	ILA-13.74 Million ≈ $-36.85K	-3.762x	-321.61%
2010-12-31	ILA-5.68 Million ≈ $-15.24K	ILA-9.65 Million ≈ $-25.87K	1.697x	--

About Medivie Therapeutic Ltd

TA:MDVI Israel Machinery, Tools, Heavy Vehicles, Trains & Ships

Market Cap

$366.37K

ILA136.66 Million ILA

Market Cap Rank

#31163 Global

#460 in Israel

Share Price

ILA47.50

Change (1 day)

+5.32%

52-Week Range

ILA40.00 - ILA138.00

All Time High

ILA140000.00